International Assets Investment Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

International Assets Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,935	Closed	-$26K	–	982
2023 Q1	$26K	Buy	+2,935	New	+$29K	﹤0.01%	767
2021 Q2	–	Sell	-2,162	Closed	-$23K	–	1755
2021 Q1	$23K	Buy	2,162 +1,206	+126%	+$13.8K	﹤0.01%	1262
2020 Q4	$9K	Buy	+956	New	+$9.16K	﹤0.01%	1475

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

International Assets Investment Management's TEVA Position: Q2 2023 in Review

International Assets Investment Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2023, closing a stake of 2,935 shares — an estimated $26K sold.

International Assets Investment Management first reported a position in TEVA in Q4 2020 and held it in 3 quarters. The position peaked at $26K in Q1 2023. 428 funds tracked by Wall St. Rank hold TEVA as of Q2 2023.

International Assets Investment Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2023 after selling out during the quarter.
International Assets Investment Management sold 2,935 Teva Pharmaceutical Industries Limited shares in Q2 2023, an estimated $26K.
International Assets Investment Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2020 and held it in 3 quarters.
International Assets Investment Management's Teva Pharmaceutical Industries Limited position peaked at $26K in Q1 2023.
428 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2023.

Based on International Assets Investment Management's 13F filing for Q2 2023, filed 20 Jul 2023.